Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain

Lei Du-Cuny, Zuohe Song, Sylvestor Moses, Garth Powis, Eugene A Mash, Emmanuelle Meuillet, Shuxing Zhang

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Computational modeling continues to play an important role in novel therapeutics discovery and development. In this study, we have investigated the use of in silico approaches to develop inhibitors of the pleckstrin homology (PH) domain of AKT (protein kinase B). Various docking/scoring schemes have been evaluated, and the best combination was selected to study the system. Using this strategy, two hits were identified and their binding behaviors were investigated. Robust and predictive QSAR models were built using the k nearest neighbor (kNN) method to study their cellular permeability. Based on our in silico results, long flexible aliphatic tails were proposed to improve the Caco-2 penetration without affecting the binding mode. The modifications enhanced the AKT inhibitory activity of the compounds in cell-based assays, and increased their activity as in vivo antitumor testing.

Original languageEnglish (US)
Pages (from-to)6983-6992
Number of pages10
JournalBioorganic and Medicinal Chemistry
Volume17
Issue number19
DOIs
StatePublished - Oct 1 2009

Fingerprint

Proto-Oncogene Proteins c-akt
Computer Simulation
Assays
Quantitative Structure-Activity Relationship
Testing
Permeability
Pleckstrin Homology Domains
platelet protein P47
Therapeutics

Keywords

  • Akt inhibitors
  • Anticancer drugs
  • Cell permeability
  • In silico drug design
  • Metabolism
  • Molecular docking/scoring
  • Pleckstrin homology domain
  • QSAR

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. / Du-Cuny, Lei; Song, Zuohe; Moses, Sylvestor; Powis, Garth; Mash, Eugene A; Meuillet, Emmanuelle; Zhang, Shuxing.

In: Bioorganic and Medicinal Chemistry, Vol. 17, No. 19, 01.10.2009, p. 6983-6992.

Research output: Contribution to journalArticle

Du-Cuny, Lei ; Song, Zuohe ; Moses, Sylvestor ; Powis, Garth ; Mash, Eugene A ; Meuillet, Emmanuelle ; Zhang, Shuxing. / Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. In: Bioorganic and Medicinal Chemistry. 2009 ; Vol. 17, No. 19. pp. 6983-6992.
@article{e8138bef12c244a2b74fadc8af8c7594,
title = "Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain",
abstract = "Computational modeling continues to play an important role in novel therapeutics discovery and development. In this study, we have investigated the use of in silico approaches to develop inhibitors of the pleckstrin homology (PH) domain of AKT (protein kinase B). Various docking/scoring schemes have been evaluated, and the best combination was selected to study the system. Using this strategy, two hits were identified and their binding behaviors were investigated. Robust and predictive QSAR models were built using the k nearest neighbor (kNN) method to study their cellular permeability. Based on our in silico results, long flexible aliphatic tails were proposed to improve the Caco-2 penetration without affecting the binding mode. The modifications enhanced the AKT inhibitory activity of the compounds in cell-based assays, and increased their activity as in vivo antitumor testing.",
keywords = "Akt inhibitors, Anticancer drugs, Cell permeability, In silico drug design, Metabolism, Molecular docking/scoring, Pleckstrin homology domain, QSAR",
author = "Lei Du-Cuny and Zuohe Song and Sylvestor Moses and Garth Powis and Mash, {Eugene A} and Emmanuelle Meuillet and Shuxing Zhang",
year = "2009",
month = "10",
day = "1",
doi = "10.1016/j.bmc.2009.08.022",
language = "English (US)",
volume = "17",
pages = "6983--6992",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "19",

}

TY - JOUR

T1 - Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain

AU - Du-Cuny, Lei

AU - Song, Zuohe

AU - Moses, Sylvestor

AU - Powis, Garth

AU - Mash, Eugene A

AU - Meuillet, Emmanuelle

AU - Zhang, Shuxing

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Computational modeling continues to play an important role in novel therapeutics discovery and development. In this study, we have investigated the use of in silico approaches to develop inhibitors of the pleckstrin homology (PH) domain of AKT (protein kinase B). Various docking/scoring schemes have been evaluated, and the best combination was selected to study the system. Using this strategy, two hits were identified and their binding behaviors were investigated. Robust and predictive QSAR models were built using the k nearest neighbor (kNN) method to study their cellular permeability. Based on our in silico results, long flexible aliphatic tails were proposed to improve the Caco-2 penetration without affecting the binding mode. The modifications enhanced the AKT inhibitory activity of the compounds in cell-based assays, and increased their activity as in vivo antitumor testing.

AB - Computational modeling continues to play an important role in novel therapeutics discovery and development. In this study, we have investigated the use of in silico approaches to develop inhibitors of the pleckstrin homology (PH) domain of AKT (protein kinase B). Various docking/scoring schemes have been evaluated, and the best combination was selected to study the system. Using this strategy, two hits were identified and their binding behaviors were investigated. Robust and predictive QSAR models were built using the k nearest neighbor (kNN) method to study their cellular permeability. Based on our in silico results, long flexible aliphatic tails were proposed to improve the Caco-2 penetration without affecting the binding mode. The modifications enhanced the AKT inhibitory activity of the compounds in cell-based assays, and increased their activity as in vivo antitumor testing.

KW - Akt inhibitors

KW - Anticancer drugs

KW - Cell permeability

KW - In silico drug design

KW - Metabolism

KW - Molecular docking/scoring

KW - Pleckstrin homology domain

KW - QSAR

UR - http://www.scopus.com/inward/record.url?scp=69949181643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69949181643&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2009.08.022

DO - 10.1016/j.bmc.2009.08.022

M3 - Article

VL - 17

SP - 6983

EP - 6992

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 19

ER -